Retinal Detachment - Demographic and Clinical Survey
- Conditions
- Rhegmatogenous Retinal Detachment
- Registration Number
- NCT01845571
- Lead Sponsor
- Medical University of Vienna
- Brief Summary
Background:
Rhegmatogenous retinal detachment is an ophthalmic emergency that, without surgical repair, often leads to blindness. The incidence is about 1/10000/year. The leading causes are myopia and aging which cause retinal tears often resulting in retinal detachment. Patients commonly experience photopsia, floaters, and peripheral visual field loss.
Two different general surgical treatment options exist for retinal detachment; scleral buckling or vitrectomy. However, the precise indications for each approach have not been well established. Correct classification of the retinal detachment is important. The first step is to decide whether an intra- or extra-ocular surgical approach is more appropriate. Simple rhegmatogenous retinal detachments are usually treated extraocularly with scleral buckling surgery, whereas more complicated cases require intraocular primary pars plana vitrectomy and one or more of gas, silicone oil, laser therapy, or cryotherapy.
Study objectives:
The purpose of this study is to evaluate different surgical techniques for the treatment of retinal detachment. Data relating to retinal status before treatment, surgical treatment, post-operative anatomy and visual acuity, post-operative OCT, and intra- and post-operative complications will be collected.
Vitreous cytokines will also be analyzed to monitor intravitreal inflammation as a result of retinal detachment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 400
Patients who received surgery due to retinal detachment between January 2008 and Decemebr 2012.
Surgery was performed by either Ass.Prof.PD.Dr. Stefan Sacu or Prof.Dr. Michael Georgopoulos
If patients had prior vitrectomy or scleral buckel. If patients had no adequate follow-up.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vision 2 years Aqueous cytokine Levels baseline
- Secondary Outcome Measures
Name Time Method Surgical Data 2 years OCT baseline
Trial Locations
- Locations (1)
Insitute of Ophthalmology and Optometry, Medical University of Vienna
🇦🇹Vienna, Austria